<DOC>
	<DOCNO>NCT01143584</DOCNO>
	<brief_summary>To study effect rapid escalation Cabergoline comparison conventional dosing macroprolactinomas . Rapid escalation cabergoline may help early normalization prolactin shrinkage tumor mass , thus decrease cumulative dose cabergoline altogether .</brief_summary>
	<brief_title>Efficacy Rapid Escalation Cabergoline Comparison Conventional Dosing Prolactin Secreting Macroadenomas .</brief_title>
	<detailed_description>The efficacy cabergoline dose relate determined percentage Dopamine 2 receptor occupancy prolong receptor affinity . Activation membrane receptor target cell response proportional degree receptor occupancy . Greater drug concentration , great bind receptor occupancy great efficacy drug . Receptor occupancy increase either use high dose cabergoline rapid escalation cabergoline . The patient , respond increase dosage cabergoline , probably increase receptor occupancy high dos . Rapid escalation dose cabergoline another approach increase drug concentration increase occupancy receptor . Earlier decrease serum prolactin level rapid escalation may help reduce cumulative dose cabergoline total duration treatment . Though study high dos cabergoline perform prolactinomas normalization prolactin level almost 100 % , systematic study use rapid escalation cabergoline prolactinomas lack except one Bhansali et al . In study , serum prolactin become normal 93 per cent patient mean duration 8.2 wk . The mean decrease serum prolactin 99 per cent four week , however similar decrease ( 93 99 % ) prolactin achieve study time lag 48 160 wk . This support notion rapid hike dos cabergoline decrease serum prolactin level faster becomes normal majority patient earlier6 . However uncontrolled study limit number subject . Therefore present study plan study efficacy rapid escalation Cabergoline versus conventional dosing patient macroprolactinomas . Rapid escalation cabergoline dose may help early normalization prolactin shrinkage tumor mass , thus decrease cumulative dose cabergoline altogether .</detailed_description>
	<mesh_term>Prolactinoma</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>Males female present 1 . Prolactin secrete macroadenomas ( ≥10 mm maximum diameter ) 2 . With/without visual complaint 3 . With /without parasellar suprasellar extension 4 . Treatment Naïve 1 . On treatment dopamine agonist . 2 . Taking drug influence prolactin Levels . 3 . Systemic disease like Chronic Kidney Disease , Chronic Lung Disease 4 . Other secondary cause hyperprolactinemia . 5 . Prolactin secrete microadenomas 6 . Pregnancy follow 7 . Prolactinoma part MEN1 Syndrome 8 . History suggestive recent apoplexy ( 3 month ) 9 . Contraindication cabergoline therapy like pre exist psychosis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Prolactin</keyword>
	<keyword>Cabergoline</keyword>
	<keyword>Macroadenomas</keyword>
	<keyword>escalation</keyword>
</DOC>